Sonoma Pharmaceuticals
SNOA
#9966
Rank
NZ$5.84 M
Marketcap
$4.36
Share price
-1.91%
Change (1 day)
-22.62%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2024 (TTM): -NZ$7.64 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are NZ$12.69 Million. In 2023 the company made an earning of -NZ$7.57 Million, an increase over its 2022 earnings that were of -NZ$11.05 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$7.64 Million0.93%
2023 -NZ$7.57 Million-31.5%
2022 -NZ$11.05 Million16.86%
2021 -NZ$9.46 Million194.32%
2020 -NZ$3.22 Million-58.76%
2019 -NZ$7.79 Million-65.66%
2018 -NZ$22.68 Million4.84%
2017 -NZ$21.64 Million-2.17%
2016 -NZ$22.12 Million32.12%
2015 -NZ$16.74 Million-307.74%
2014 NZ$8.05 M-197.5%
2013 -NZ$8.27 Million
2010 -NZ$12.91 Million-14.02%
2009 -NZ$15.02 Million-57.28%
2008 -NZ$35.15 Million-8.03%
2007 -NZ$38.22 Million3.85%
2006 -NZ$36.8 Million39.31%
2005 -NZ$26.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$30.95 Million 291.80%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.42 Billion 5,179.22%๐Ÿ‡บ๐Ÿ‡ธ USA